Clinical Scorecard: At the Forefront of Spine Surgery: Robotics, Biologics, & Clinical Trials at UCI Health

At a Glance

Key Highlights

• UCI Health leads in outpatient robotic spine surgery enabling same-day or next-day discharge after fusion procedures.
• Clinical trials at UCI focus on next-generation artificial discs, lumbar facet replacements, patient-specific implants, and biologics like bone morphogenic protein.
• Motion-preserving technologies are expanding to reduce loss of spinal motion compared to traditional fusion surgeries.

Guideline-Based Recommendations

Diagnosis

• Careful patient selection based on inclusion criteria for clinical trials and surgical candidacy.

Management

• Utilize robotic-assisted minimally invasive techniques for enhanced precision and reduced hospital stay.
• Consider motion-preserving implants such as artificial discs or facet replacements when appropriate.
• Employ biologics like bone morphogenic protein to improve fusion rates in indicated cases.

Monitoring & Follow-up

• Long-term follow-up of 2 to 3 years or more to assess safety and efficacy of new devices and biologics.

Risks

• Ensure patient safety through strict adherence to clinical trial protocols and selection criteria.

Patient & Prescribing Data

Patients enrolled in clinical trials for spinal fusion, motion preservation, and biologic augmentation

Clinical trials provide access to cutting-edge devices and biologics tailored to patient-specific anatomy and bone density, aiming to improve outcomes and safety.

Clinical Best Practices

• Adopt ultra minimally invasive spine surgery techniques including endoscopy and robotics.
• Engage in multidisciplinary collaboration with engineering and stem cell research for innovation.
• Participate in rigorous clinical trials to advance spine surgery technologies and validate safety and efficacy.
• Use patient-specific implants matched to bone density for improved fusion outcomes.

References

• UCI Health Spine Care